Hummingbird Bioscience Stock

hummingbirdbioscience.comHealthcareFounded: 2015

Hummingbird Bioscience, founded in 2015, is a data-driven precision biotherapeutics team discovering and developing transformative biologic medicines for hard-to-treat diseases. The Hummingbird Bioscience model combines computational and systems biology, and wet lab drug discovery in a multi-disciplinary, collaborative environment spanning initial discovery through clinical development.

Register for Details

For more details on financing and valuation for Hummingbird Bioscience, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Hummingbird Bioscience.

Register Today

Hummingbird Bioscience investors also invested in these private companies

Team

Management Team

Piers Ingram Ph.D
Co-Founder, Executive Director & Chief Executive Officer
Leah DiMascio
Chief Operations Officer
Konrad Paszkiewicz Ph.D
Chief Technology Officer
Jerome Boyd-Kirkup Ph.D
Co-Founder & Chief Scientific Officer
Lan Zhang
Co-Founder
Joshua House JD
Chief Financial Officer
Eric Rowinsky MD
Chief Medical Officer

Board Members

Chik Wai Chiew
Heritas Capital
Daniel Estes Ph.D
Frazier Healthcare Partners
Kenneth Harrison Ph.D
Novo Holdings
Kiel Kim
SK Group
Victor Tong Jr.
Decheng Capital

Other companies like Hummingbird Bioscience in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector